全球糖尿病護理設備市場規模、佔有率和成長分析：按類型、患者照護環境和地區 - 行業預測（2024-2031）

2022年全球糖尿病護理設備市場規模為28億美元，從2023年的32.6億美元成長到2031年的109億美元，在預測期間（2024-2031年）預計複合年成長率為16.3%。

據國際糖尿病聯盟 (IDF) 稱，無法治療方法的危及生命的慢性糖尿病已達到流行病水平，影響全球約 5.37 億成年人。特別是，與久坐生活方式相關的 2 型糖尿病盛行率不斷上升，預計將推動對糖尿病護理設備的需求。心臟病、腎衰竭和截肢等慢性糖尿病併發症凸顯了對有效管理解決方案的迫切需求。世界衛生組織 (WHO) 強調，由於肥胖率上升和健康意識下降，糖尿病在低收入和中等收入國家變得越來越普遍。隨著疾病負擔的增加以及旨在提高意識的各種政府舉措，糖尿病護理設備市場預計在未來幾年將出現顯著成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析和影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

糖尿病護理設備市場規模：按類型，複合年成長率（2024-2031）

• 市場概況
• 血糖值監測系統
  • 自我血糖監測系統
  • 連續血糖監測系統
  • 試紙/試紙
  • 採血針/穿刺裝置
• 胰島素給藥裝置
  • 胰島素幫浦
  • 胰島素筆
  • 胰島素注射器和針頭
• 糖尿病管理行動應用程式

糖尿病護理設備市場規模：依患者照護環境分類，複合年成長率（2024-2031）

• 市場概況
• 自我/家庭保健
• 醫院和糖尿病診所

糖尿病護理設備市場規模，複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• F. Hoffman-La Roche Ltd.
• Abbott
• Ascensia Diabetes Care Holdings AG
• Dexcom, Inc.
• Medtronic PLC
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Arkray, Inc.
• Sanofi
• Novo Nordisk A/S
• Terumo Corporation
• Ypsomed
• Sinocare, Inc.
• AgaMatrix Holdings LLC
• SD Biosensor, Inc.
• Microgene Diagnostic Systems Pvt. Ltd.
• Dr. Morepen
• Bionime Corporation
• Rossmax International Ltd.

結論和建議

Global Diabetes Care Devices Market size was valued at USD 2.8 billion in 2022 and is poised to grow from USD 3.26 billion in 2023 to USD 10.90 billion by 2031, growing at a CAGR of 16.3% during the forecast period (2024-2031).

Diabetes, a chronic and life-threatening condition with no cure, has reached pandemic levels, affecting approximately 537 million adults globally, according to the International Diabetes Federation (IDF). The growing prevalence, particularly of Type 2 diabetes linked to sedentary lifestyles, is expected to drive demand for diabetes care devices. Chronic diabetes complications, including heart attacks, kidney failure, and amputations, underscore the urgent need for effective management solutions. The World Health Organization highlights that diabetes is more prevalent in low to middle-income countries due to rising obesity rates and limited health awareness. As the disease burden increases, alongside various government initiatives aimed at raising awareness, the diabetes care devices market is anticipated to experience significant growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Care Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Care Devices Market Segmental Analysis

Global Diabetes Care Devices Market is segmented by Type, Patient Care Settings, and region. Based on Type, the market is segmented into Blood glucose monitoring systems, Insulin delivery devices, and Diabetes management mobile applications. Based on Patient Care Settings, the market is segmented into Self/Home Healthcare, and Hospitals & Diabetes Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Care Devices Market

The Global Diabetes Care Devices market is witnessing significant growth driven by the increasing prevalence of sedentary lifestyles and the associated rise in diabetes cases. With more individuals diagnosed with Type-2 diabetes due to unhealthy habits, the need for effective management solutions has become critical. According to the International Diabetes Federation, approximately 537 million adults are living with diabetes, which increases the urgency for care devices. Growing awareness among patients, alongside the demand for insulin-delivery systems, is further propelling market expansion. Emerging economies present significant opportunities due to a higher incidence of diabetes among middle and lower-middle-class populations, combined with a rising interest in technological advancements by manufacturers.

Restraints in the Global Diabetes Care Devices Market

The growth of the Global Diabetes Care Devices market is expected to encounter challenges during the forecast period, primarily due to the inaccessibility and low awareness of diabetes management technologies in remote and underdeveloped regions. Many patients in these areas lack access to essential diabetes care devices, which significantly limits market penetration. Additionally, the lengthy registration processes for new devices, coupled with complications surrounding reimbursement, further exacerbate these challenges. Consequently, these factors collectively hinder the overall adoption and growth of diabetes care devices in markets that are already struggling with healthcare access and awareness.

Market Trends of the Global Diabetes Care Devices Market

The Global Diabetes Care Devices market is experiencing significant growth driven by the rising adoption of self-monitoring blood glucose meters and test strips, alongside increased demand for continuous glucose monitoring (CGM) systems. This trend is particularly pronounced in developing countries, where greater awareness of diabetes management is influencing consumer behavior. Additionally, the WHO highlights the alarming statistic that over 60% of the global population lacks sufficient physical activity, exacerbating the risk of type 2 diabetes associated with increased body weight. As health consciousness continues to grow, market players are poised to capitalize on lucrative opportunities in this expanding sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Diabetes Care Devices Market Size by Type & CAGR (2024-2031)

• Market Overview
• Blood glucose monitoring systems
  • Self-monitoring blood glucose monitoring systems
  • Continuous glucose monitoring systems
  • Test strips/test papers
  • Lancets/lancing devices
• Insulin delivery devices
  • Insulin pumps
  • Insulin pens
  • Insulin syringes and needles
• Diabetes management mobile applications

Global Diabetes Care Devices Market Size by Patient Care Settings & CAGR (2024-2031)

• Market Overview
• Self/Home Healthcare
• Hospitals & Diabetes Specialty Clinics

Global Diabetes Care Devices Market Size & CAGR (2024-2031)

• North America (Type, Patient Care Settings)
  • US
  • Canada
• Europe (Type, Patient Care Settings)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Patient Care Settings)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Patient Care Settings)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patient Care Settings)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffman-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Holdings LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microgene Diagnostic Systems Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Morepen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionime Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation